NeoGenomics NEO Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $186.67M-1.8% | $190.17M+1.3% | $187.8M+3.6% | $181.33M+7.9% | $168.04M-2.3% | ||
| $105.81M-1.0% | $106.83M-0.5% | $107.35M+3.2% | $104.07M+9.8% | $94.79M0.0% | ||
| $80.86M-3.0% | $83.34M+3.6% | $80.45M+4.1% | $77.26M+5.5% | $73.25M-5.2% | ||
| 43.3%-0.5pp | 43.8%+1.0pp | 42.8%+0.2pp | 42.6%-1.0pp | 43.6%-1.3pp | ||
| $9.53M+3.9% | $9.18M+5.6% | $8.69M-3.6% | $9.02M-11.4% | $10.18M+27.8% | ||
| $23.83M+1.7% | $23.44M+7.5% | $21.81M-9.4% | $24.08M+6.1% | $22.68M+1.5% | ||
| $65.74M+3.5% | $63.51M-9.1% | $69.87M-2.6% | $71.75M+5.2% | $68.21M+7.2% | ||
| $99.11M+2.4% | $96.76M-10.0% | $107.46M-14.0% | $124.89M+23.6% | $101.07M+5.7% | ||
| -$18.24M-36.0% | -$13.41M+50.3% | -$27.01M+43.3% | -$47.63M-71.2% | -$27.83M-51.2% | ||
| -9.8%-2.7pp | -7.1%+7.3pp | -14.4%+11.9pp | -26.3%-9.7pp | -16.6%-5.9pp | ||
| $598K-0.2% | $599K-0.7% | $603K-35.4% | $933K-42.3% | $1.62M-0.4% | ||
| -$12K-114% | $84K+125% | -$335K-170% | $482K+642% | $65K+115% | ||
| -$17.58M-41.7% | -$12.41M+53.0% | -$26.39M+42.4% | -$45.82M-78.6% | -$25.66M-59.1% | ||
| -$472K+81.3% | -$2.53M-441% | $740K+202% | -$724K-372% | $266K+133% | ||
| -$17.11M-73.1% | -$9.88M+63.6% | -$27.13M+39.8% | -$45.09M-73.9% | -$25.92M-69.2% | ||
| -9.2%-4.0pp | -5.2%+9.3pp | -14.4%+10.4pp | -24.9%-9.4pp | -15.4%-6.5pp | ||
| -$1.83M-161% | $2.98M+128% | -$10.58M+65.2% | -$30.36M-201% | -$10.1M-4,640% | ||
| -1%-2.5pp | 1.6%+7.2pp | -5.6%+11.1pp | -16.7%-10.7pp | -6%-5.9pp | ||
| -$18.24M-36.0% | -$13.41M+50.3% | -$27.01M+43.3% | -$47.63M-71.2% | -$27.83M-51.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is NeoGenomics's revenue?
- NeoGenomics (NEO) generated $746.0M in revenue over the trailing twelve months, up 10.9% year over year.
- Is NeoGenomics profitable?
- NeoGenomics is not currently profitable: it reported a net loss of $99.2M over the trailing twelve months, a -13.3% net margin.
- What are NeoGenomics's profit margins?
- Gross margin is 43.2% and operating margin is -14.2%, with a -13.3% net margin.
- What is NeoGenomics's earnings per share?
- NeoGenomics's diluted EPS over the trailing twelve months is $-0.76.
- Where does NeoGenomics's income statement data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
